Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Dominant mutations in ubiquitously expressed superoxide dismutase (SOD1) cause familial ALS by provoking premature death of adult motor neurons. To test whether mutant damage to cell types beyond motor neurons is required for the onset of motor neuron disease, we generated chimeric mice in which all motor neurons and oligodendrocytes expressed mutant SOD1 at a level sufficient to cause fatal, early-onset motor neuron disease when expressed ubiquitously, but did so in a cellular environment containing variable numbers of non-mutant, non-motor neurons. Despite high-level mutant expression within 100% of motor neurons and oligodendrocytes, in most of these chimeras, the presence of WT non-motor neurons substantially delayed onset of motor neuron degeneration, increasing disease-free life by 50%. Disease onset is therefore non-cell autonomous, and mutant SOD1 damage within cell types other than motor neurons and oligodendrocytes is a central contributor to initiation of motor neuron degeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in disease models have shown that mutations in SOD1 associated with amyotrophic lateral sclerosis affect not only motor neurons, but also non-neuronal cells in ways that promote neurodegeneration8”
From CRISPR-based functional genomics for neurological disease (2020) · cites this paper as [8]
Citations
Cites
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Self-citationWong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Vande Velde, C., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,429
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341 · cited 1×
“Motor neuron disease from expression of mutant SOD1 has previously been demonstrated to arise from loss of the pool of large caliber motor axons (21), including for end-stage mutant SOD1G37R (22) (see also Fig.”
BackgroundSelf-citationAstrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Self-citationAstrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 6×
“Thus, although the number of Olig / ::SOD1G37R chimeric mice produced for this study was relatively small because of the complexity of the experimental design, our data establish that onset of motor neuron degeneration is non-cell autonomous and that non-autonomous cell contributors to onset may be distinguishable fro…”
BackgroundInfluentialSelf-citationMolecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100
Self-citationLu, Q. R., Sun, T., Zhu, Z., Ma, N., Garcia, M., Stiles, C. D., & Rowitch, D. H. (2002) · Cell · doi:10.1016/s0092-8674(02)00678-5 · Cited by 1,073
Self-citation
Cited by
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Decoding ALS: from genes to mechanism
Taylor, J. P., Brown, R. H., & Cleveland, D. W. (2016) · Nature · doi:10.1038/nature20413 · Cited by 2,066
Self-citationMicroglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710
Non–cell autonomous toxicity in neurodegenerative disorders: ALS and beyond
Ilieva, H., Polymenidou, M., & Cleveland, D. W. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908164 · Cited by 1,008
Self-citationThe changing scene of amyotrophic lateral sclerosis
Robberecht, W., & Philips, T. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3430 · Cited by 957
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Kang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599
Self-citationvan Rheenen, W., van der Spek, R. A. A., Bakker, M. K., van Vugt, J. J. F. A., Hop, P. J., Zwamborn, R. A. J., de Klein, N., Westra, H.-J., Bakker, O. B., Deelen, P., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00973-1 · Cited by 542
Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology
Ballas, N., Lioy, D. T., Grunseich, C., & Mandel, G. (2009) · Nature Neuroscience · doi:10.1038/nn.2275 · Cited by 466
Functions of Astrocytes and their Potential As Therapeutic Targets
Kimelberg, H. K., & Nedergaard, M. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.006 · Cited by 408
Microglia in ALS: The Good, The Bad, and The Resting
Henkel, J. S., Beers, D. R., Zhao, W., & Appel, S. H. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9171-5 · Cited by 353
“Furthermore, Yamanaka et al. (2008a) dem- onstrated that the presence of WT non-neuronal cells substantially delayed motoneuron degeneration, again indicating that other cells, such as glial cells, contribute to disease.”
BackgroundSerio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300398110 · Cited by 345
“We next sought to determine whether mutant M337V astrocytes exert a non-cell-autonomous toxic effect on MNs, similar to that described for mutant SOD1 rodent astrocytes (1, 8, 9, 31, 32).”
BackgroundInflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
Dynamics and Mechanisms of CNS Myelination
Bercury, K. K., & Macklin, W. B. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.01.016 · Cited by 320
Misfolded Mutant SOD1 Directly Inhibits VDAC1 Conductance in a Mouse Model of Inherited ALS
Israelson, A., Arbel, N., Da Cruz, S., Ilieva, H., Yamanaka, K., Shoshan-Barmatz, V., & Cleveland, D. W. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.019 · Cited by 315
Self-citationMoloney, E. B., de Winter, F., & Verhaagen, J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00252 · Cited by 307
Rodent Models of Amyotrophic Lateral Sclerosis
Philips, T., & Rothstein, J. D. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0567s69 · Cited by 294
Extracellular mutant SOD1 induces microglial‐mediated motoneuron injury
Zhao, W., Beers, D. R., Henkel, J. S., Zhang, W., Urushitani, M., Julien, J., & Appel, S. H. (2010) · Glia · doi:10.1002/glia.20919 · Cited by 288
Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
Guttenplan, K. A., Weigel, M. K., Adler, D. I., Couthouis, J., Liddelow, S. A., Gitler, A. D., & Barres, B. A. (2020) · Nature Communications · doi:10.1038/s41467-020-17514-9 · Cited by 278
Johann, S., Heitzer, M., Kanagaratnam, M., Goswami, A., Rizo, T., Weis, J., Troost, D., & Beyer, C. (2015) · Glia · doi:10.1002/glia.22891 · Cited by 277
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
Glial cells in amyotrophic lateral sclerosis
Philips, T., & Rothstein, J. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.015 · Cited by 250
Watanabe, S., Ilieva, H., Tamada, H., Nomura, H., Komine, O., Endo, F., Jin, S., Mancias, P., Kiyama, H., & Yamanaka, K. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606403 · Cited by 231
Self-citationThe multi-dimensional roles of astrocytes in ALS
Yamanaka, K., & Komine, O. (2018) · Neuroscience Research · doi:10.1016/j.neures.2017.09.011 · Cited by 211
Self-citationHuang, C., Zhou, H., Tong, J., Chen, H., Liu, Y.-J., Wang, D., Wei, X., & Xia, X.-G. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002011 · Cited by 206
Resveratrol Improves Motoneuron Function and Extends Survival in SOD1G93A ALS Mice
Mancuso, R., del Valle, J., Modol, L., Martinez, A., Granado-Serrano, A. B., Ramirez-Núñez, O., Pallás, M., Portero-Otin, M., Osta, R., & Navarro, X. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0253-y · Cited by 206
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 203
Forsberg, K., Andersen, P. M., Marklund, S. L., & Brännström, T. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0805-3 · Cited by 199
Shi, P., Wei, Y., Zhang, J., Gal, J., & Zhu, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100366 · Cited by 83
Sun, S., Sun, Y., Ling, S.-C., Ferraiuolo, L., McAlonis-Downes, M., Zou, Y., Drenner, K., Wang, Y., Ditsworth, D., Tokunaga, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520639112 · Cited by 196
Self-citationNussbaum-Krammer, C. I., Neto, M. F., Brielmann, R. M., Pedersen, J. S., & Morimoto, R. I. (2015) · Journal of Visualized Experiments · doi:10.3791/52321 · Cited by 179
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Innate and adaptive immune responses in the CNS
Waisman, A., Liblau, R., & Becher, B. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00141-6 · Cited by 173
The Complex Molecular Biology of Amyotrophic Lateral Sclerosis (ALS)
Redler, R. L., & Dokholyan, N. V. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00002-3 · Cited by 172
Li, Q., Vande Velde, C., Israelson, A., Xie, J., Bailey, A. O., Dong, M.-Q., Chun, S.-J., Roy, T., Winer, L., Yates, J. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014862107 · Cited by 169
Self-citationRavits, J., Appel, S., Baloh, R. H., Barohn, R., Rix Brooks, B., Elman, L., Floeter, M. K., Henderson, C., Lomen-Hoerth, C., Macklis, J. D., et al. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.778548 · Cited by 169
Parisi, C., Arisi, I., D'Ambrosi, N., Storti, A. E., Brandi, R., D'Onofrio, M., & Volonté, C. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.491 · Cited by 152
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Mancuso, R., Oliván, S., Rando, A., Casas, C., Osta, R., & Navarro, X. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0140-y · Cited by 165
CRISPR-based functional genomics for neurological disease
Kampmann, M. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0373-z · Cited by 163
Amyotrophic lateral sclerosis: Problems and prospects
Sreedharan, J., & Brown, R. H. (2013) · Annals of Neurology · doi:10.1002/ana.24012 · Cited by 138
Extracellular Vesicles and a Novel Form of Communication in the Brain
Basso, M., & Bonetto, V. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00127 · Cited by 161
RNA-binding proteins with prion-like domains in ALS and FTLD-U
Gitler, A. D., & Shorter, J. (2011) · Prion · doi:10.4161/pri.5.3.17230 · Cited by 161
Astrogliosis in Amyotrophic Lateral Sclerosis: Role and Therapeutic Potential of Astrocytes
Vargas, M. R., & Johnson, J. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.012 · Cited by 133
Murray, L. M., Talbot, K., & Gillingwater, T. H. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01061.x · Cited by 153
The past, present and future of stem cell clinical trials for ALS
Thomsen, G. M., Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.02.021 · Cited by 151
Inflammation in ALS and SMA: Sorting out the good from the evil
Papadimitriou, D., Le Verche, V., Jacquier, A., Ikiz, B., Przedborski, S., & Re, D. B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 132
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147
Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice
Ito, Y., Yamada, M., Tanaka, H., Aida, K., Tsuruma, K., Shimazawa, M., Hozumi, I., Inuzuka, T., Takahashi, H., & Hara, H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.013 · Cited by 141
Glial Cells in Amyotrophic Lateral Sclerosis
Lasiene, J., & Yamanaka, K. (2011) · Neurology Research International · doi:10.1155/2011/718987 · Cited by 110
Self-citationRojas, F., Cortes, N., Abarzua, S., Dyrda, A., & van Zundert, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00024 · Cited by 113
Ullah, M. F., Ahmad, A., Bhat, S. H., Abu-Duhier, F. M., Barreto, G. E., & Ashraf, G. M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.003 · Cited by 113
CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis
Tateishi, T., Yamasaki, R., Tanaka, M., Matsushita, T., Kikuchi, H., Isobe, N., Ohyagi, Y., & Kira, J. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.03.004 · Cited by 127
Induced pluripotent stem cells: a new revolution for clinical neurology?
Mattis, V. B., & Svendsen, C. N. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70022-9 · Cited by 124
Bravo-Hernandez, M., Tadokoro, T., Navarro, M. R., Platoshyn, O., Kobayashi, Y., Marsala, S., Miyanohara, A., Juhas, S., Juhasova, J., Skalnikova, H., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0674-1 · Cited by 114
Self-citationCNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tefera, T. W., Steyn, F. J., Ngo, S. T., & Borges, K. (2021) · Cell & Bioscience · doi:10.1186/s13578-020-00511-2 · Cited by 125
Neuroinflammation in motor neuron disease.
Komine, O., & Yamanaka, K. (2015) · PubMed · doi:10.18999/nagjms.77.4.537 · Cited by 65
Self-citationPatel, P., Kriz, J., Gravel, M., Soucy, G., Bareil, C., Gravel, C., & Julien, J.-P. (2014) · Molecular Therapy · doi:10.1038/mt.2013.239 · Cited by 110
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Cappello, V., & Francolini, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102092 · Cited by 119
“On the other hand, it was shown that these cells played a relevant role in modulating ALS progression, since delayed microglial activation and slowed disease progression in SOD1 mice were observed [97,98] by reducing their level of expression of mutant SOD1.”
BackgroundNizzardo, M., Simone, C., Rizzo, F., Ruggieri, M., Salani, S., Riboldi, G. M., Faravelli, I., Zanetta, C., Bresolin, N., Comi, G. P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt425 · Cited by 119
ER Dysfunction and Protein Folding Stress in ALS
Matus, S., Valenzuela, V., Medinas, D. B., & Hetz, C. (2013) · International Journal of Cell Biology · doi:10.1155/2013/674751 · Cited by 101
Hefferan, M. P., Gálik, J., Kakinohana, O., Sekerková, G., Santucci, C., Marsala, S., Navarro, R., Hruška-Plocháň, M., Johe, K. K., Feldman, E. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042614 · Cited by 115
Self-citationMultimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis
Teng, Y. D., Benn, S. C., Kalkanis, S. N., Shefner, J. M., Onario, R. C., Cheng, B., Lachyankar, M. B., Marconi, M., Li, J., Yu, D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004579 · Cited by 115
Fujii, H., Matsubara, K., Sakai, K., Ito, M., Ohno, K., Ueda, M., & Yamamoto, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.04.001 · Cited by 116
Ageing as a risk factor for ALS/FTD
Niccoli, T., Partridge, L., & Isaacs, A. M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx247 · Cited by 102
Thomsen, G. M., Avalos, P., Ma, A. A., Alkaslasi, M., Cho, N., Wyss, L., Vit, J.-P., Godoy, M., Suezaki, P., Shelest, O., et al. (2018) · Stem Cells · doi:10.1002/stem.2825 · Cited by 93
Vinsant, S., Mansfield, C., Jimenez‐Moreno, R., Moore, V. D. G., Yoshikawa, M., Hampton, T. G., Prevette, D., Caress, J., Oppenheim, R. W., & Milligan, C. (2013) · Brain and Behavior · doi:10.1002/brb3.143 · Cited by 105
Tefera, T. W., & Borges, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00611 · Cited by 100
Sunyach, C., Michaud, M., Arnoux, T., Bernard‐Marissal, N., Aebischer, J., Gourdou‐Latyszenok, V., Gouarné, C., Raoul, C., Pruss, R. M., Bordet, T., et al. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.013 · Cited by 105
Importance of Functional Loss of FUS in FTLD/ALS
Ishigaki, S., & Sobue, G. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00044 · Cited by 91
Neuroinflammation in motor neuron disease
Endo, F., Komine, O., & Yamanaka, K. (2016) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12309 · Cited by 91
Self-citationMotor neuron disease and frontotemporal dementia: sometimes related, sometimes not
Hardy, J., & Rogaeva, E. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.006 · Cited by 94
Park, S., Kim, H.-T., Yun, S., Kim, I., Lee, J., Lee, I.-S., & Park, K. I. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.7.054 · Cited by 94
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Pandya, R. S., Zhu, H., Li, W., Bowser, R. P., Friedlander, R. M., & Wang, X. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1415-0 · Cited by 90
Crosio, C., Valle, C., Casciati, A., Iaccarino, C., & Carrì, M. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017187 · Cited by 71
Provenzano, F., Torazza, C., Bonifacino, T., Bonanno, G., & Milanese, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015430 · Cited by 85
Shiwaku, H., Yoshimura, N., Tamura, T., Sone, M., Ogishima, S., Watase, K., Tagawa, K., & Okazawa, H. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.116 · Cited by 84
Turner, B. J., Ackerley, S., Davies, K. E., & Talbot, K. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp550 · Cited by 69
Izrael, M., Slutsky, S. G., Admoni, T., Cohen, L., Granit, A., Hasson, A., Itskovitz-Eldor, J., Krush Paker, L., Kuperstein, G., Lavon, N., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0890-5 · Cited by 74
Iron Metabolism of the Skeletal Muscle and Neurodegeneration
Hałoń, M., Borkowska, A., Herman-Antosiewicz, A., & Antosiewicz, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00165 · Cited by 82
Niu, C., Zhang, J. Y., Gao, F., Yang, L., Jia, M., Zhu, H., & Gong, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047056 · Cited by 82
Autophagy in Astrocytes and its Implications in Neurodegeneration
Sung, K., & Jiménez-Sánchez, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.041 · Cited by 80
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 81
Dibaj, P., Steffens, H., Zschüntzsch, J., Nadrigny, F., Schomburg, E. D., Kirchhoff, F., & Neusch, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017910 · Cited by 65
What are activated and reactive glia and what is their role in neurodegeneration?
Bennett, M. L., & Viaene, A. N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105172 · Cited by 77
Nefussy, B., Artamonov, I., Deutsch, V., Naparstek, E., Nagler, A., & Drory, V. E. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960902933809 · Cited by 77
Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013011 · Cited by 77
Nicaise, C., Mitrečić, D., Falnikar, A., & Lepore, A. C. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.380 · Cited by 75
Cozzolino, M., Pesaresi, M. G., Gerbino, V., Großkreutz, J., & Carrì, M. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4328 · Cited by 74
Romer, S. H., Seedle, K., Turner, S. M., Li, J., Baccei, M. L., & Crone, S. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.033 · Cited by 74
Bryson, J. B., Hobbs, C., Parsons, M. J., Bosch, K. D., Pandraud, A., Walsh, F. S., Doherty, P., & Greensmith, L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds215 · Cited by 71
Chiarini, A., Gui, L., Viviani, C., Armato, U., & Prà, I. D. (2023) · Biomedicines · doi:10.3390/biomedicines11040999 · Cited by 72
ALS pathogenesis: Recent insights from genetics and mouse models
Swarup, V., & Julien, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.006 · Cited by 72
Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Simone, C., Falcone, M., Riboldi, G. M., Govoni, A., Bresolin, N., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq293 · Cited by 72
Mitochondria-associated membranes: A hub for neurodegenerative diseases
Liu, J., & Yang, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112890 · Cited by 71
Herron, L. R., & Miles, G. B. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.031 · Cited by 69
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Haukedal, H., & Freude, K. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.02.004 · Cited by 68
Astrocyte–neuron co-culture on microchips based on the model of SOD mutation to mimic ALS
Kunze, A., Lengacher, S., Dirren, E., Aebischer, P., Magistretti, P. J., & Renaud, P. (2013) · Integrative Biology · doi:10.1039/c3ib40022k · Cited by 61
Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis
Hoye, M. L., Regan, M. R., Jensen, L. A., Lake, A. M., Reddy, L. V., Vidensky, S., Richard, J.-P., Maragakis, N. J., Rothstein, J. D., Dougherty, J. D., et al. (2018) · Brain · doi:10.1093/brain/awy182 · Cited by 63
Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Riancho, J., Ruiz-Soto, M., Berciano, M. T., Berciano, J., & Lafarga, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00250 · Cited by 56
Metadata
- Authors
- Yamanaka, K., Boillee, S., Roberts, E. A., Garcia, M. L., McAlonis-Downes, M., Mikse, O. R., Cleveland, D. W., & Goldstein, L. S. B.
- Affiliations
- RIKEN Center for Brain Science (JP)
- *Ludwig Institute for Cancer Research and Department of Medicine and Neuroscience, University of California at San Diego, La Jolla, CA 92093;
- Howard Hughes Medical Institute (US)
- University of California San Diego (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-05-27
- Volume
- 105
- Issue
- 21
- Pages
- 7594-7599
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2396671
- OpenAlex
- W2027047473
- Cited by
- 309
- References
- 29
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 21 · 2021: 12 · 2020: 18 · 2019: 15 · 2018: 25 · 2017: 10 · 2016: 14 · 2015: 22 · 2014: 20 · 2013: 25 · 2012: 30
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Muscular Dystrophy Association
- Johns Hopkins University
- Uehara Memorial Foundation
- Ludwig Institute for Cancer Research
- Institut National de la Santé et de la Recherche Médicale
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health
- U.S. Public Health Service (P30 NSO47101)
- Japan Society for the Promotion of Science (19591021, 27036, 19044048)
- National Institute of Neurological Disorders and Stroke (NS 27036, P30NS047101, R37NS027036, R01NS027036)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- amyotrophic lateral sclerosis, SOD1 mutations, familial ALS, motor neuron degeneration, oligodendrocytes, chimeric mice, disease initiation
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Genes, Dominant, Mice, Transgenic, Motor Neurons, Mutation, Oligodendroglia, Superoxide Dismutase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.